Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126959561 | 12695956 | 1 | I | 20160501 | 20160818 | 20160829 | 20160829 | EXP | GB-SA-2016SA153008 | AVENTIS | 6.00 | YR | C | M | Y | 0.00000 | 20160829 | CN | GB | GR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126959561 | 12695956 | 1 | PS | FLUDARA | FLUDARABINE PHOSPHATE | 1 | Unknown | U | UNK | 20038 | 30 | MG/KG | QD | ||||||
126959561 | 12695956 | 2 | SS | BUSILVEX | BUSULFAN | 1 | Unknown | (1,1 MG/KG X 16 DOSES | U | UNK | 0 | 1.1 | MG/KG | ||||||
126959561 | 12695956 | 3 | SS | THIOTEPA. | THIOTEPA | 1 | Unknown | U | UNK | 0 | 5 | MG/KG | BID | ||||||
126959561 | 12695956 | 4 | SS | CYCLOSPORINE. | CYCLOSPORINE | 1 | Unknown | U | UNK | 0 | 4 | MG/KG | |||||||
126959561 | 12695956 | 5 | SS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | U | UNK | 0 | 10 | MG/M**2 | |||||||
126959561 | 12695956 | 6 | SS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | U | UNK | 0 | 10 | MG/M**2 | |||||||
126959561 | 12695956 | 7 | SS | ANTITHYMOCYTE IMMUNOGLOBULIN | THYMOCYTE IMMUNE GLOBULIN NOS | 1 | Unknown | U | UNK | 0 | 7.5 | MG/KG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126959561 | 12695956 | 1 | Prophylaxis against graft versus host disease |
126959561 | 12695956 | 2 | Prophylaxis against graft versus host disease |
126959561 | 12695956 | 3 | Prophylaxis against graft versus host disease |
126959561 | 12695956 | 4 | Prophylaxis against graft versus host disease |
126959561 | 12695956 | 5 | Prophylaxis against graft versus host disease |
126959561 | 12695956 | 6 | Prophylaxis against graft versus host disease |
126959561 | 12695956 | 7 | Prophylaxis against graft versus host disease |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126959561 | 12695956 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126959561 | 12695956 | Epstein-Barr virus infection | |
126959561 | 12695956 | Febrile neutropenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126959561 | 12695956 | 1 | 20160307 | 20160311 | 0 | |
126959561 | 12695956 | 2 | 20160307 | 0 | ||
126959561 | 12695956 | 3 | 20160307 | 20160307 | 0 | |
126959561 | 12695956 | 4 | 20160307 | 0 | ||
126959561 | 12695956 | 5 | 20160307 | 20160307 | 0 | |
126959561 | 12695956 | 6 | 20160309 | 20160309 | 0 | |
126959561 | 12695956 | 7 | 20160307 | 0 |